Quality of Life After Total Pancreatectomy Versus Pancreaticoduodenectomy for Pancreatic and Periampullary Neoplasms: A Narrative Review
Cancers · 20.11.2026 · 18 (22) · 3714
DOI: 10.3390/cancers18223714 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 20.11.2026. Verfasst von Sofia Zachari und 6 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Total pancreatectomy (TP) causes complete endocrine and exocrine insufficiency, and concern about its effect on quality of life (QoL) has limited its use compared with pancreaticoduodenectomy (PD). This narrative review critically appraises studies that directly compared patient-reported QoL after TP and PD for pancreatic and periampullary neoplasms.
Methods
Following SANRA recommendations, we searched PubMed/MEDLINE and Scopus (to 12 October 2026) and reference lists of relevant reviews for comparative studies using a validated QoL instrument. Results were extracted from the original publications as effect estimates, and each study’s risk of bias was appraised narratively.
Results
Ten studies (eleven reports; 2007–2026; 251 TP and 438 PD patients in total, with fewer contributing to individual outcomes) were identified. Only one enrolled exclusively patients with pancreatic ductal adenocarcinoma, and only two measured QoL repeatedly. No study detected a statistically significant difference in global health status, but confidence intervals were wide. Lower role, social, physical, or emotional functioning and more fatigue, insomnia, or financial difficulty after TP were reported in five studies, mainly in the first postoperative year, and diabetes-related distress and hypoglycemia tended to be greater after TP. Most studies were small, cross-sectional, and restricted to survivors.
Conclusions
Current evidence does not show that TP leads to worse overall QoL than PD, but neither does it demonstrate equivalence; TP appears to carry specific functional and diabetes-related burdens, particularly early after surgery, although longitudinal data are very limited. The certainty of this evidence is low. Prospective, cancer-specific studies with preoperative baselines and repeated measurements are needed.
Zitieren
APA
Zachari, S., Pitsilka, M. M., Manolakis, A., Tepetes, K., Passas, I., Bakalis, V., & Zacharoulis, D. (2026). Quality of Life After Total Pancreatectomy Versus Pancreaticoduodenectomy for Pancreatic and Periampullary Neoplasms: A Narrative Review. Cancers, 18(22), 3714. https://doi.org/10.3390/cancers18223714
Vancouver
Zachari S, Pitsilka MM, Manolakis A, Tepetes K, Passas I, Bakalis V, et al. Quality of Life After Total Pancreatectomy Versus Pancreaticoduodenectomy for Pancreatic and Periampullary Neoplasms: A Narrative Review. Cancers. 2026;18(22):3714. doi:10.3390/cancers18223714
BibTeX
@article{Zachari2026,
author = {Zachari, Sofia and Pitsilka, Maria M. and Manolakis, Anastasios and Tepetes, Konstantinos and Passas, Ioannis and Bakalis, Vissarion and Zacharoulis, Dimitrios},
title = {Quality of Life After Total Pancreatectomy Versus Pancreaticoduodenectomy for Pancreatic and Periampullary Neoplasms: A Narrative Review},
journal = {Cancers},
year = {2026},
volume = {18},
number = {22},
pages = {3714},
doi = {10.3390/cancers18223714}
}
EUVIMED